Clinical Trials Directory

Trials / Completed

CompletedNCT00648973

To Determine if Diphenhydramine Works for Nasal Congestion at Two Different Doses

Evaluation of Nasal Congestion Clinical Efficacy for Diphenhydramine 25 mg and Diphenhydramine 50 mg in Seasonal Allergic Rhinitis: a Randomized, Double-blind, Placebo and Pseudoephedrine Controlled Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
1,021 (actual)
Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide · Industry
Sex
All
Age
12 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The study was to determine if the drug worked to relieve nasal congestion experienced by people with seasonal allergies.

Detailed description

Subjects who met the inclusion/exclusion criteria were enrolled into the placebo run-in phase of the study on Day -7 (prerandomization, Visit 1). Baseline symptom scores were established during this run-in phase. Subjects with moderate nasal congestion who took at least 80% of their study medication during the run-in phase were eligible for enrollment in the two-week double-blind phase of the study and were randomized on Day 1 (randomization, Visit 2). They were treated for two weeks with their assigned medication. The severity of signs/symptoms were evaluated by the subjects every morning and night and by the investigator at each visit on Day 7 and Day 14. In addition, the subject and investigator provided a global evaluation of response to treatment on Day 7 and Day 14. Safety was evaluated by adverse events reported during the study, vital signs, and the incidence of somnolence.

Conditions

Interventions

TypeNameDescription
DRUGDiphenhydramine 50 mgThree times daily: two diphenhydramine 25 mg capsules Twice daily: one pseudoephedrine-matching placebo tablet
DRUGDiphenhydramine 25 mgThree times daily: one diphenhydramine 25 mg capsule and one diphenhydramine-matching placebo capsule Twice daily: one pseudoephedrine-matching placebo tablet
DRUGPseudoephedrine 120 mgThree times daily: two diphenhydramine-matching placebo capsules Twice daily: one pseudoephedrine 120 mg tablet

Timeline

Start date
2006-11-01
Primary completion
2007-05-01
Completion
2007-05-01
First posted
2008-04-01
Last updated
2011-08-22

Locations

12 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00648973. Inclusion in this directory is not an endorsement.